News

20th Anniversary of the Centre for Blood Research (CBR)

20th Anniversary of the Centre for Blood Research (CBR)

Event organized by 2022-2023 CBR Graduate Awards Program (GAP) recipients. The day will feature several events that celebrate the journey of the CBR from its inception to the present.

CSTM 2023: Reflections from Canadian Blood Services research and physician trainees in transfusion medicine

CSTM 2023: Reflections from Canadian Blood Services research and physician trainees in transfusion medicine

Read the responses from Canadian Blood Services research & CBR trainees Tseday Tegegn, and Emel Islamzada.

An Interview with Dr. Sutherland, Research Associate in Dr. Ed Pryzdial Lab

An Interview with Dr. Sutherland, Research Associate in Dr. Ed Pryzdial Lab

“Meet the Researcher”: Dr. Sutherland

Lipid Nanoparticle Freight Comparison 

Lipid Nanoparticle Freight Comparison 

The Kastrup group compared the effects of two ionizable cations lipids for RNA therapies targeting the liver

CBR Travel Awards: Attending the Gordon Research Conference

CBR Travel Awards: Attending the Gordon Research Conference

PhD Candidate Colton Strong presented his poster on lipid nanoparticles and mRNA at the 2023 Cell Biology of Megakaryocytes and Platelets – Gordon Research Conference.

Equity, Diversity & Inclusion (EDI) workshop with Dr. Maria Tokuyama

Equity, Diversity & Inclusion (EDI) workshop with Dr. Maria Tokuyama

The Centre for Blood Research (CBR) is pleased to hold a Workshop “Equity, Diversity & Inclusion (EDI)” on Tuesday May 16, 2023 from 2-3:30 pm PT, with Dr. Maria Tokuyama, Assistant Professor, Department of Microbiology & Immunology, UBC.

Jefferies Lab publication “A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours”

Jefferies Lab publication “A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours”

Publication from Dr. Jefferies Lab: “A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours”Published: May 15, 2023 https://doi.org/10.3389/fphar.2023.1119607

Jefferies Lab publication “The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain”

Jefferies Lab publication “The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain”

Publication from Dr. Jefferies Lab: The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain.Published: April 20, 2023 https://www.nature.com/articles/s41598-023-30054-8

Jefferies Lab publication “Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours”

Jefferies Lab publication “Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours”

Publication from Dr. Jefferies Lab: “Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours”Published: Feb 22, 2023 https://doi.org/10.3389/fimmu.2022.982082

Dr. Md Mahamud ur Rashid, received Canadian Institutes of HealthResearch (CIHR) Fellowship Award

Dr. Md Mahamud ur Rashid, received Canadian Institutes of HealthResearch (CIHR) Fellowship Award

Dr. Md Mahamud ur Rashid, Postdoctoral Fellow in Dr. Pryzdial Lab, received CIHR Fellowship Award to investigate the role of host-derived clotting factors in viral pathogenesis and infection, targeting these for the development of broad-spectrum antiviral agents.